Discovery, Innovation, Growth
So pleased for my friend Mathai Mammen, founder Greg Verdine, and all of Parabilis Medicines on this remarkable milestone!
Parabilis Medicines said it would sell 33.5 million shares at $20 apiece, for a total of $670 million.
It's been a busy first half of 2024 for the Life Sciences Practice at Park Square!
Increasingly, companies are identifying opportunities to leverage AI/ML and other sophisticated data science capabilities to enrich and...…
Park Square is so pleased to have been of service to the Deep Genomics Board of Directors. Congratulations to Brian, Brendan, and Chip on...
So pleased to have been of service to our amazing client, Character Biosciences! Best wishes to Laura and the entire Character team...
Watch this space! Congratulations to our outstanding client, Faeth Therapeutics, on their Series A and emergence into prime time!
The goal is to transform cancer treatment with nutrition and make it the fourth “pillar” in the oncology regimen, which to...…
As a free user, you can like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net
